{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T14:30:38Z","timestamp":1794234638807,"version":"4.9.0"},"reference-count":182,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jceh.2026.103474","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:25:03Z","timestamp":1769127903000},"page":"103474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Indian National Association for Study of the Liver Guidance Document on Difficult to Treat Autoimmune Hepatitis"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3901-6969","authenticated-orcid":false,"given":"Sunil","family":"Taneja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Mehtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Koshy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1989-1099","authenticated-orcid":false,"given":"Ajay","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3525-9381","authenticated-orcid":false,"given":"Amit","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3594-5856","authenticated-orcid":false,"given":"Anil","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7105-1540","authenticated-orcid":false,"given":"Anil C.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Saraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0902-4140","authenticated-orcid":false,"given":"Anshu","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8567-1676","authenticated-orcid":false,"given":"Arka","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8410-9665","authenticated-orcid":false,"given":"Arun","family":"Valsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashim","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6680-7227","authenticated-orcid":false,"given":"Ashish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5878-2661","authenticated-orcid":false,"given":"Barjesh C.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Panackel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmesh","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Jothimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6196-9198","authenticated-orcid":false,"given":"Gaurav","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gourdas","family":"Choudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshad","family":"Devarbhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2902-9213","authenticated-orcid":false,"given":"Kaushal","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna D.","family":"Devadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumita","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9540-3686","authenticated-orcid":false,"given":"Manas K.","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-0036","authenticated-orcid":false,"given":"Narendra","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6347-0988","authenticated-orcid":false,"given":"Omesh","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padaki N.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-463X","authenticated-orcid":false,"given":"Praveen","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhi","family":"Maiwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhana B.","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5677-7140","authenticated-orcid":false,"given":"Sanjiv","family":"Saigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivaram P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8973-3408","authenticated-orcid":false,"given":"Sunil","family":"Dadhich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Zacharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrat K.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv K.","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh K.","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha K.","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-2664","authenticated-orcid":false,"given":"Ajay","family":"Duseja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2026.103474_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jceh.2026.103474_bib2","first-page":"65","article-title":"Global incidence and prevalence of autoimmune hepatitis, 1970\u20132022: a systematic review and meta-analysis","volume":"1","author":"Hahn","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.jceh.2026.103474_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"Autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s11894-015-0484-7","article-title":"Management of difficult cases of autoimmune hepatitis","volume":"18","author":"Lammert","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jceh.2026.103474_bib5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jceh.2022.11.002","article-title":"Spectrum of autoimmune liver disease and real-world treatment experience from a tertiary care hospital","volume":"13","author":"Taneja","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: international autoimmune hepatitis group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12072-021-10170-1","article-title":"The Asian Pacific association for the study of the liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis","volume":"15","author":"Wang","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2026.103474_bib11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","article-title":"Systematic review of response criteria and endpoints in autoimmune hepatitis by the international autoimmune hepatitis group","volume":"76","author":"Pape","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jhep.2021.03.023","article-title":"Towards personalised medicine in autoimmune hepatitis: measurement of thiopurine metabolites results in higher biochemical response rates","volume":"75","author":"Candels","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MEG.0000000000001019","article-title":"A systematic review and meta-analysis of second-line immunosuppressants for autoimmune hepatitis treatment","volume":"30","author":"De Lemos-Bonotto","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cgh.2017.09.063","article-title":"Efficacy and safety of mycophenolate mofetil in patients with autoimmune hepatitis and suboptimal outcomes after standard therapy","volume":"16","author":"Roberts","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib15","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.cgh.2017.06.001","article-title":"Efficacy and safety of mycophenolate mofetil and tacrolimus as second-line therapy for patients with autoimmune hepatitis","volume":"15","author":"Efe","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/apt.13907","article-title":"Expert clinical management of autoimmune hepatitis in the real world","volume":"45","author":"Liberal","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2026.103474_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","article-title":"EASL clinical practice guidelines on the management of autoimmune hepatitis","volume":"83","author":"Dalekos","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jhep.2023.11.032","article-title":"An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis","volume":"80","author":"Snijders","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib19","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1097\/HEP.0000000000001089","article-title":"Efficacy and safety of Infliximab in patients with autoimmune hepatitis","volume":"81","author":"Efe","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cgh.2017.07.003","article-title":"Methotrexate therapy for autoimmune hepatitis","volume":"16","author":"Haridy","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib21","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3109\/00365521.2014.998271","article-title":"Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use","volume":"50","author":"Ytting","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib22","first-page":"1155","article-title":"Calcineurin inhibitors in the treatment of adult autoimmune hepatitis: a systematic review","volume":"10","author":"Baven-Pronk","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413578","article-title":"Pathogenesis of autoimmune hepatitis\u2014cellular and molecular mechanisms","volume":"22","author":"Sirbe","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2026.103474_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000322693","article-title":"A case of autoimmune hepatitis treated with rituximab","volume":"4","author":"Barth","year":"2010","journal-title":"Case Reports in Gastroenterology"},{"key":"10.1016\/j.jceh.2026.103474_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2013\/512624","article-title":"Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy","volume":"27","author":"Burak","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jhepr.2019.10.005","article-title":"Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: results from the international autoimmune hepatitis group","volume":"1","author":"Than","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2026.103474_bib27","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1111\/liv.15970","article-title":"Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: results from the ColHai registry","volume":"44","author":"Riveiro-Barciela","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2026.103474_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003194","article-title":"B-Cell activating factor belonging to the tumor necrosis factor family and Interferon-\u03b3-Inducible Protein-10 in autoimmune hepatitis","volume":"95","author":"Nishikawa","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.jceh.2026.103474_bib29","article-title":"Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis","volume":"2","author":"Arvaniti","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2026.103474_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13075-015-0529-1","article-title":"Proteasome inhibitors as experimental therapeutics of autoimmune diseases","volume":"17","author":"Verbrugge","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jceh.2026.103474_bib31","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/hep.30059","article-title":"Low-dose Interleukin-2 for refractory autoimmune hepatitis","volume":"68","author":"Lim","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.molimm.2020.05.014","article-title":"Hepatocytes paradoxically affect intrahepatic IFN-\u03b3 production in autoimmune hepatitis due to Gal-9 expression and TLR2\/4 ligand release","volume":"123","author":"Mo","year":"2020","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jceh.2026.103474_bib33","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/gast.2001.24227","article-title":"Autoimmune hepatitis: clinical challenges","volume":"120","author":"Manns","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2026.103474_bib34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","author":"Stravitz","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1872-034X.2011.00808.x","article-title":"Acute presentation of autoimmune hepatitis: does it exist? A published work review","volume":"41","author":"Takahashi","year":"2011","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2026.103474_bib36","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/lt.25451","article-title":"Acute severe autoimmune hepatitis: corticosteroids or liver transplantation?","volume":"25","author":"Rahim","year":"2019","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2026.103474_bib37","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.dld.2018.02.015","article-title":"Clinical and prognostic implications of acute onset of autoimmune hepatitis: an Italian multicentre study","volume":"50","author":"Muratori","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2026.103474_bib38","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gr\u00f8nb\u00e6k","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib39","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/j.1440-1746.2007.05048.x","article-title":"Spectrum of autoimmune liver diseases in Western India","volume":"22","author":"Amarapurkar","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-230X-5-27","article-title":"Autoimmune hepatitis in India: profile of an uncommon disease","volume":"5","author":"Choudhuri","year":"2005","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib41","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jhep.2014.05.021","article-title":"Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome","volume":"61","author":"Yeoman","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib42","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jhep.2016.03.023","article-title":"Usefulness of corticosteroids as first-line therapy in patients with acute severe autoimmune hepatitis","volume":"65","author":"Moenne-Loccoz","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/jclinpath-2016-204271","article-title":"Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients","volume":"70","author":"Canh","year":"2017","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jceh.2026.103474_bib44","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/MCG.0000000000002022","article-title":"Prevalence of acute on chronic liver failure in autoimmune hepatitis, treatment response and mortality burden assessment","volume":"58","author":"Patil","year":"2024","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib45","article-title":"Approach to the patient with acute severe autoimmune hepatitis","volume":"2","author":"Rahim","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2026.103474_bib46","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00535-010-0316-3","article-title":"Clinicopathological features of severe and fulminant forms of autoimmune hepatitis","volume":"46","author":"Yasui","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib47","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/liv.15217","volume":"42","author":"Lohse","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2026.103474_bib48","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1542-3565(04)00246-0","article-title":"Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis","volume":"2","author":"Kessler","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib49","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.24141","article-title":"Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis","volume":"53","author":"Yeoman","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib50","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jhep.2020.12.033","article-title":"Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: the SURFASA score","volume":"74","author":"De Martin","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/hepr.13252","article-title":"Prompt initiation of high-dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis","volume":"49","author":"Zachou","year":"2019","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2026.103474_bib52","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/lt.21036","article-title":"Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis","volume":"13","author":"Ichai","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2026.103474_bib53","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.30205","article-title":"Flare of autoimmune hepatitis causing acute on chronic liver failure: diagnosis and response to corticosteroid therapy","volume":"70","author":"Anand","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib54","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s12072-023-10482-4","article-title":"Identifying the early predictors of non-response to steroids in patients with flare of autoimmune hepatitis causing acute-on-chronic liver failure","volume":"17","author":"Sharma","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2026.103474_bib55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice \u2013 evidence-based approach from the writing committee of the American society for apheresis: the ninth special issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jceh.2026.103474_bib56","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3748\/wjg.v26.i2.219","article-title":"Plasma exchange in patients with acute and acute-on-chronic liver failure: a systematic review","volume":"26","author":"Tan","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib57","doi-asserted-by":"crossref","first-page":"e831","DOI":"10.1016\/j.cgh.2021.01.036","article-title":"Standard-volume plasma exchange improves outcomes in patients with acute liver failure: a randomized controlled trial","volume":"20","author":"Maiwall","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","article-title":"High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial","volume":"64","author":"Larsen","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/LVT.0000000000000231","article-title":"Plasma exchange for acute and acute-on-chronic liver failure: a systematic review and meta-analysis","volume":"30","author":"Beran","year":"2024","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2026.103474_bib60","doi-asserted-by":"crossref","first-page":"298-298","DOI":"10.1080\/00365521.2020.1867890","article-title":"Tacrolimus as second-line therapy in acute severe autoimmune hepatitis","volume":"56","author":"Efe","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib61","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ueg2.12582","article-title":"Outcomes of patients with acute severe autoimmune hepatitis: predictors of non-response to corticosteroids and need for liver transplantation","volume":"12","author":"Eshraghian","year":"2024","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jceh.2026.103474_bib62","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/MEG.0000000000000353","article-title":"Fulminant presentation of autoimmune hepatitis","volume":"27","author":"Mendizabal","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib63","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.dld.2022.08.035","article-title":"Severe acute autoimmune hepatitis: how to early predict who will not respond to corticosteroids and needs urgent liver transplantation?","volume":"54","author":"Jo\u00e3o","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2026.103474_bib64","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4254\/wjh.v8.i28.1157","article-title":"Cirrhosis and autoimmune liver disease: current understanding","volume":"8","author":"Liberal","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib65","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.4103\/0366-6999.191760","article-title":"Autoimmune hepatitis-related cirrhosis","volume":"129","author":"Li","year":"2016","journal-title":"Chin Med J"},{"key":"10.1016\/j.jceh.2026.103474_bib66","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000063","article-title":"Transjugular liver biopsy: safe Even in patients with severe coagulopathies and multiple biopsies","volume":"10","author":"Sue","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib67","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2026.103474_bib68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MOG.0000000000001150","article-title":"Management of autoimmune hepatitis-related decompensated cirrhosis: current evidence and clinical decision-making","volume":"42","author":"Arvaniti","year":"2026","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib69","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib70","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00004836-200105000-00014","article-title":"Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy","volume":"32","author":"Cotler","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib71","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1046\/j.1440-1746.2001.02602.x","article-title":"Autoimmune hepatitis in the Indian subcontinent: 7 years experience","volume":"16","author":"Gupta","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib72","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12016-016-8583-2","article-title":"The management of autoimmune hepatitis patients with decompensated cirrhosis: real-world experience and a comprehensive review","volume":"52","author":"Wang","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jceh.2026.103474_bib73","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/jgh3.12451","article-title":"Presence and type of decompensation affects outcomes in autoimmune hepatitis upon treatment with corticosteroids","volume":"5","author":"Sharma","year":"2021","journal-title":"JGH Open"},{"key":"10.1016\/j.jceh.2026.103474_bib74","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1007\/s10620-025-09129-1","article-title":"Efficacy, safety and long-term clinical outcomes of low-dose versus high-dose prednisolone induction in autoimmune hepatitis: a propensity score-matched analysis","volume":"70","author":"Aggarwal","year":"2025","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2026.103474_bib75","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2026.103474_bib76","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jhep.2023.04.033","article-title":"Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): an expert opinion meeting report","volume":"79","author":"Andrade-Bellido","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib77","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bj\u00f6rnsson","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib78","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.dld.2014.08.040","article-title":"Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study","volume":"46","author":"Licata","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2026.103474_bib79","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/hep4.1959","article-title":"Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports","volume":"6","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2026.103474_bib80","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jceh.2021.06.021","article-title":"Herbal immune booster-induced liver injury in the COVID-19 pandemic - a case series","volume":"11","author":"Nagral","year":"2021","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib81","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4254\/wjh.v6.i4.160","article-title":"Drug-induced autoimmune liver disease: a diagnostic dilemma of an increasingly reported disease","volume":"6","author":"Castiella","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib82","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14218\/JCTH.2018.00053","article-title":"Liver fibrosis helps to distinguish autoimmune hepatitis from DILI with autoimmune features: a review of twenty cases","volume":"7","author":"Febres-Aldana","year":"2019","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib84","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/hep4.1904","article-title":"Tinospora cordifolia (Giloy)\u2013Induced liver injury during the COVID-19 pandemic\u2014multicenter nationwide study from India","volume":"6","author":"Kulkarni","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2026.103474_bib85","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.jhep.2024.01.023","article-title":"Distinction of autoimmune hepatitis from drug-induced autoimmune like hepatitis: the answer lies at the interface","volume":"81","author":"Alkashash","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12664-017-0815-8","article-title":"Clinical outcomes, histopathological patterns, and chemical analysis of ayurveda and herbal medicine associated with severe liver injury\u2014A single-center experience from southern India","volume":"37","author":"Philips","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib87","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug-induced liver injury","volume":"15","author":"de Boer","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib88","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2021.08.024","article-title":"Infliximab-induced liver injury: clinical phenotypes, autoimmunity and the role of corticosteroid treatment","volume":"76","author":"Bj\u00f6rnsson","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib89","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/apt.17373","article-title":"Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: an international, multicentre, propensity score-matched analysis","volume":"57","author":"Niu","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2026.103474_bib90","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000322298","article-title":"Steroid and ursodesoxycholic acid combination therapy in severe drug-induced liver injury","volume":"84","author":"Wree","year":"2011","journal-title":"Digestion"},{"key":"10.1016\/j.jceh.2026.103474_bib91","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jgh3.12054","article-title":"Differential characteristics in drug-induced autoimmune hepatitis","volume":"2","author":"Mart\u00ednez-Casas","year":"2018","journal-title":"JGH Open"},{"key":"10.1016\/j.jceh.2026.103474_bib92","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the international autoimmune hepatitis group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib93","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.3390\/jcm12227047","article-title":"Primary biliary cholangitis (PBC)-autoimmune hepatitis (AIH) variant syndrome: clinical features, response to therapy and long-term outcome","volume":"12","author":"Graf","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jceh.2026.103474_bib94","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jhep.2004.06.001","article-title":"Genetics of autoimmune and viral liver diseases; understanding the issues","volume":"41","author":"Donaldson","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib95","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/ajg.2009.126","article-title":"The serological profile of the autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome","volume":"104","author":"Muratori","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib96","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/10446670310001642159","article-title":"Characterization of a lipoyl domain-independent b-cell autoepitope on the human branched-chain acyltransferase in primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis","volume":"10","author":"Csepregi","year":"2003","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jceh.2026.103474_bib97","article-title":"Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy","volume":"6","author":"Stoelinga","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2026.103474_bib98","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib99","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody\u2013positive autoimmune hepatitis","volume":"48","author":"O'Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib101","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib102","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","article-title":"Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"43","author":"L\u00fcth","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib103","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","article-title":"High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitisNote","volume":"33","author":"van Buuren","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib104","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejim.2008.06.004","article-title":"High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis","volume":"20","author":"Olsson","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jceh.2026.103474_bib105","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3390\/jcm9051449","article-title":"Treatment of overlap syndromes in autoimmune liver disease: a systematic review and meta-analysis","volume":"9","author":"Freedman","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jceh.2026.103474_bib106","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","article-title":"Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid","volume":"35","author":"Joshi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib107","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cgh.2013.12.010","article-title":"Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-hispanics","volume":"12","author":"Levy","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1965492","article-title":"Efficacy and safety of immunosuppressive therapy for PBC\u2013AIH overlap syndrome accompanied by decompensated cirrhosis: a real-world study","volume":"2018","author":"Fan","year":"2018","journal-title":"Canadian Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib109","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/MEG.0000000000000075","article-title":"Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis","volume":"26","author":"Efe","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib110","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cgh.2013.09.021","article-title":"Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis","volume":"12","author":"Efe","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib111","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cld.2005.10.009","article-title":"Autoimmune hepatitis and primary sclerosing cholangitis","volume":"10","author":"Alvarez","year":"2006","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2026.103474_bib112","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","article-title":"Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis","volume":"14","author":"Perdigoto","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib113","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/00365520310005172","article-title":"Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients","volume":"38","author":"Boberg","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib114","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2026.103474_bib115","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1572-0241.2001.03777.x","article-title":"High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis","volume":"96","author":"Harnois","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib116","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","article-title":"A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2026.103474_bib117","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-Year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2026.103474_bib118","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib119","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.27074","article-title":"Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis","volume":"60","author":"Wunsch","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib120","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/hep4.1421","article-title":"A prospective trial of withdrawal and reinstitution of ursodeoxycholic acid in pediatric primary sclerosing cholangitis","volume":"3","author":"Black","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2026.103474_bib121","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.27927","article-title":"Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis","volume":"63","author":"Tabibian","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib122","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.12232","article-title":"Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study","volume":"37","author":"Tabibian","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2026.103474_bib123","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ajg.2008.14","article-title":"Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study","volume":"104","author":"Silveira","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib124","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/MJT.0000000000000102","article-title":"Prospective clinical trial of rifaximin therapy for patients with primary sclerosing cholangitis","volume":"24","author":"Tabibian","year":"2017","journal-title":"Am J Therapeut"},{"key":"10.1016\/j.jceh.2026.103474_bib125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.15403\/jgld.2014.1121.254.rah","article-title":"Triple blinded, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of oral vancomycin in primary sclerosing cholangitis: a pilot study","volume":"25","author":"Rahimpour","year":"2016","journal-title":"J Gastrointestinal Liver Dis"},{"key":"10.1016\/j.jceh.2026.103474_bib126","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jceh.2019.02.007","article-title":"Indian national association for the study of the liver\u2014federation of obstetric and gynaecological societies of India position statement on management of liver diseases in pregnancy","volume":"9","author":"Arora","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib127","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/hep.32410","article-title":"Autoimmune hepatitis in pregnancy: pearls and pitfalls","volume":"76","author":"Chung","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib128","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41395-018-0181-x","article-title":"Non-invasive markers (ALBI and APRI) predict pregnancy outcomes in women with chronic liver disease","volume":"114","author":"Gonsalkorala","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib129","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.transproceed.2011.02.026","article-title":"Pregnancy outcome in female liver transplant recipients","volume":"43","author":"Costa","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2026.103474_bib130","article-title":"Pre-existing liver disease in pregnancy: cirrhosis, autoimmune hepatitis and liver transplantation","volume":"44\u201345","author":"Mili\u0107","year":"2020","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib131","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jhep.2023.03.006","article-title":"EASL clinical practice guidelines on the management of liver diseases in pregnancy","volume":"79","author":"Williamson","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2025.102544","article-title":"Maternal and fetal outcomes of autoimmune hepatitis in pregnancy: a United States hospitalized patient study","volume":"49","author":"Li","year":"2025","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib133","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/apt.16924","article-title":"Systematic review with meta-analysis: outcomes of pregnancy in patients with autoimmune hepatitis","volume":"55","author":"Si","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2026.103474_bib134","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1080\/00365521.2021.1953127","article-title":"Systematic review with meta-analysis: autoimmune hepatitis in pregnancy","volume":"56","author":"El Jamaly","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1665-2681(19)30914-7","article-title":"Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome","volume":"13","author":"Rigopoulou","year":"2014","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib136","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3109\/00365521.2013.772231","article-title":"Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B\/C","volume":"48","author":"Efe","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib137","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajcp\/aqz095","article-title":"Resolution of HCV-autoimmune hepatitis overlap syndrome with antiviral treatment","volume":"152","author":"Putra","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jceh.2026.103474_bib138","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2026.103474_bib139","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1572-0241.2007.01609.x","article-title":"Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases","volume":"103","author":"W\u00f6rns","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib140","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/v15010214","article-title":"Recent advances in protective vaccines against hepatitis viruses: a narrative review","volume":"15","author":"Elbahrawy","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jceh.2026.103474_bib141","article-title":"Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease","volume":"5","author":"Zachou","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2026.103474_bib142","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s10620-016-4213-3","article-title":"Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease","volume":"61","author":"De Luca-Johnson","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2026.103474_bib143","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MCG.0000000000001817","article-title":"Patients with autoimmune hepatitis and nonalcoholic fatty liver disease","volume":"58","author":"Strzepka","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib144","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1007\/s10620-015-3795-5","article-title":"Autoimmune markers do not impact clinical presentation or natural history of steatohepatitis-related liver disease","volume":"60","author":"Ravi","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2026.103474_bib145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12072-011-9277-8","article-title":"Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network","volume":"6","author":"Vuppalanchi","year":"2012","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2026.103474_bib146","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4254\/wjh.v16.i12.1407","article-title":"Evaluation of autoimmune phenomena in patients with nonalcoholic fatty liver disease on the basis of liver pathology","volume":"16","author":"Zhu","year":"2024","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2025.101470","article-title":"Autoantibodies are associated with worse outcomes in MASLD","author":"Soria","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2026.103474_bib148","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.3748\/wjg.v27.i43.7563","article-title":"Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: a prospective multi-centre cohort study","volume":"27","author":"De Roza","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib149","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/00365520802130183","article-title":"Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study","volume":"43","author":"Werner","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103474_bib150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jhep.2009.02.026","article-title":"Rapidity of treatment response and outcome in type 1 autoimmune hepatitis","volume":"51","author":"Czaja","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib151","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/apt.12563","article-title":"Systematic review with meta-analysis: clinical manifestations and management of autoimmune hepatitis in the elderly","volume":"39","author":"Chen","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2026.103474_bib152","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2006.04.007","article-title":"Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre","volume":"45","author":"Al-Chalabi","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib153","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.21074","article-title":"Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly","volume":"43","author":"Czaja","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103474_bib154","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2026.103474_bib155","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1478-3231.2008.01904.x","article-title":"Features and consequences of untreated type 1 autoimmune hepatitis","volume":"29","author":"Czaja","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2026.103474_bib156","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1111\/j.1440-1746.2008.05347.x","article-title":"De novo autoimmune hepatitis after living donor liver transplantation is unlikely to be related to immunoglobulin subtype 4-related immune disease","volume":"23","author":"Eguchi","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib157","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/lt.25375","article-title":"Recurrent and De Novo Autoimmune Hepatitis","volume":"25","author":"Stirnimann","year":"2019","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2026.103474_bib158","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5500\/wjt.v12.i3.59","article-title":"Autoimmune hepatitis and liver transplantation: indications, and recurrent and de novo autoimmune hepatitis","volume":"12","author":"Harputluoglu","year":"2022","journal-title":"World J Transplant"},{"key":"10.1016\/j.jceh.2026.103474_bib159","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cld.1234","article-title":"Alloimmune versus autoimmune hepatitis following liver transplantation","volume":"20","author":"Harrington","year":"2022","journal-title":"Clinical Liver Disease"},{"key":"10.1016\/j.jceh.2026.103474_bib160","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"Comprehensive update of the banff working group on liver allograft pathology: introduction of antibody-mediated rejection","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2026.103474_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.101432","article-title":"Recurrence of primary disease after adult liver transplant \u2013 risk factors, early diagnosis, management, and prevention","volume":"14","author":"Mehtani","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib162","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.4254\/wjh.v7.i29.2896","article-title":"Recurrence of autoimmune liver diseases after liver transplantation","volume":"7","author":"Faisal","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib163","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2022.01.022","article-title":"Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation","volume":"77","author":"Montano-Loza","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib164","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cgh.2011.10.028","article-title":"Autoimmune hepatitis after liver transplantation","volume":"10","author":"Liberal","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib165","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2026.103474_bib166","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/MPG.0000000000002050","article-title":"Spectrum of pediatric autoimmune liver disease and validation of its diagnostic scores in Indian children","volume":"67","author":"Sood","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jceh.2026.103474_bib167","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1097\/MEG.0000000000000975","article-title":"Autoimmune acute liver failure and seronegative autoimmune liver disease in children: are they different from classical disease?","volume":"29","author":"Jain","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib168","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5223\/pghn.2021.24.2.154","article-title":"Autoimmune sclerosing cholangitis in children: a prospective case-control study","volume":"24","author":"Jain","year":"2021","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"10.1016\/j.jceh.2026.103474_bib169","doi-asserted-by":"crossref","first-page":"e1237","DOI":"10.1542\/peds.2015-0578","article-title":"Incidence and characteristics of autoimmune hepatitis","volume":"136","author":"Jim\u00e9nez-Rivera","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jceh.2026.103474_bib170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MPG.0000000000001125","article-title":"Clinical characteristics and prognosis in children and adolescents with autoimmune hepatitis and overlap syndrome","volume":"63","author":"Rodrigues","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jceh.2026.103474_bib171","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/tropej\/fmz088","article-title":"Characteristics and outcomes of autoimmune hepatitis from a tertiary paediatric centre, cape town, South Africa","volume":"66","author":"Yassin","year":"2020","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.jceh.2026.103474_bib172","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.dld.2016.03.015","article-title":"Seronegative autoimmune hepatitis in children: spectrum of disorders","volume":"48","author":"Maggiore","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2026.103474_bib173","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1445610","article-title":"Increased incidence of seronegative autoimmune hepatitis in children during SARS-CoV-2 pandemia period","volume":"15","author":"Schmutz","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jceh.2026.103474_bib174","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2010.01.037","article-title":"Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials","volume":"53","author":"Lamers","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib175","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jpeds.2013.05.042","article-title":"Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents","volume":"163","author":"Woynarowski","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.jceh.2026.103474_bib176","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1089-3261(03)00132-6","article-title":"Primary biliary cirrhosis and autoimmune cholangiopathy","volume":"8","author":"Vierling","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2026.103474_bib177","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MPG.0b013e3181d29750","article-title":"Allopurinol salvage therapy in pediatric overlap autoimmune hepatitis-primary sclerosing cholangitis with 6-MMP toxicity","volume":"51","author":"Dunkin","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jceh.2026.103474_bib178","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MPG.0000000000001530","article-title":"Second-line agents in pediatric patients with autoimmune hepatitis","volume":"65","author":"Zizzo","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jceh.2026.103474_bib179","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/AOG.0000000000005512","article-title":"Immunosuppressant medications in pregnancy","volume":"143","author":"Saad","year":"2024","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jceh.2026.103474_bib180","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2013.05.046","article-title":"Infliximab as rescue therapy in paediatric autoimmune hepatitis","volume":"59","author":"Rajanayagam","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103474_bib181","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1542\/peds.2011-1900","article-title":"Successful treatment of refractory autoimmune hepatitis with rituximab","volume":"132","author":"D'Agostino","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jceh.2026.103474_bib182","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S097368832600006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S097368832600006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T09:37:56Z","timestamp":1782812276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S097368832600006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":182,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S097368832600006X"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103474","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indian National Association for Study of the Liver Guidance Document on Difficult to Treat Autoimmune Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103474"}}